COMPANY
Bio-Tissue
FDA-cleared device company Clinical Phase 3
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Senior Technical Program Manager, Product Dev | Miami, FL, US | Oct 21, 2026 | Oct 22, 2026 |
| Sr. Manager, Reimbursement | Location not stated | Oct 21, 2026 | Oct 22, 2026 |
| Manager, Production | Miami, FL, US | Oct 21, 2026 | Oct 22, 2026 |
| Area Vice President, Ocular Sales | Location not stated | Oct 17, 2026 | Oct 17, 2026 |
| Representative, Sales (RI, E. Connecticut, E. Mass) | Location not stated | Oct 14, 2026 | Oct 15, 2026 |
Timeline
- Trial start Phase 2: A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03. source ↗
- Trial start Phase 1: TTAX03 for the Treatment of Lumbosacral Facet Joint Pain source ↗
- Trial start Phase 2: Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA source ↗
- Trial start Phase 3: Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II) source ↗
- Trial start Phase 3: Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU) source ↗
- Trial start Not phased (device or behavioral study): Amniotic Umbilical Cord Particulate During Total Knee Arthroplasty source ↗
- Trial start Phase 2: Subjects With Non-Healing Venous Leg Ulcers Treated With Standard Care Plus Cryopreserved Human Umbilical Cord (TTAX01) source ↗
- Trial start Not phased (device or behavioral study): FLO for Discogenic Pain source ↗
- Trial start Not phased (device or behavioral study): Management of Signs and Symptoms Associated With Dry Eye Disease source ↗
- Trial start 2: Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01) source ↗
- Trial start Not phased (device or behavioral study): Optimizing the Ocular Surface Prior to Cataract Surgery source ↗
- Trial start Not phased (device or behavioral study): Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K source ↗
- Trial start Not phased (device or behavioral study): In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye source ↗
- Trial start Phase 1: Demodex Blepharitis Treatment Study source ↗
- Trial start Not phased (device or behavioral study): Shunt Tube Exposure Prevention Study source ↗
Clinical trials (lead sponsor) 15
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06780306 | A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03. | Phase 2 | Completed | Dec 12, 2024 | Jan 30, 2026 (actual) |
| NCT05079035 | Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA | Phase 2 | Completed | Dec 6, 2021 | Mar 7, 2025 (actual) |
| NCT04450693 | Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II) | Phase 3 | Completed | Nov 20, 2020 | Mar 24, 2025 (actual) |
| NCT06236308 | TTAX03 for the Treatment of Lumbosacral Facet Joint Pain | Phase 1 | Withdrawn | Jul 15, 2024 | Jan 31, 2025 (estimated) |
| NCT04176120 | Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU) | Phase 3 | Completed | Jul 1, 2020 | Jan 25, 2024 (actual) |
| NCT04015219 | Management of Signs and Symptoms Associated With Dry Eye Disease | Not phased (device or behavioral study) | Terminated | Jul 18, 2018 | Oct 5, 2020 (actual) |
| NCT01551550 | Shunt Tube Exposure Prevention Study | Not phased (device or behavioral study) | Completed | 2013-06 | 2016-12 (actual) |
| NCT03230175 | Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01) | 2 | Completed | Oct 4, 2017 | Jan 10, 2019 (actual) |
| NCT03818828 | Subjects With Non-Healing Venous Leg Ulcers Treated With Standard Care Plus Cryopreserved Human Umbilical Cord (TTAX01) | Phase 2 | Completed | Feb 14, 2019 | Dec 20, 2019 (actual) |
| NCT03912116 | Amniotic Umbilical Cord Particulate During Total Knee Arthroplasty | Not phased (device or behavioral study) | Withdrawn | Apr 9, 2019 | Dec 16, 2019 (actual) |
| NCT02707406 | Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K | Not phased (device or behavioral study) | Completed | 2016-02 | Apr 14, 2017 (actual) |
| NCT02766907 | Optimizing the Ocular Surface Prior to Cataract Surgery | Not phased (device or behavioral study) | Completed | 2016-03 | 2017-01 (actual) |
| NCT03644251 | FLO for Discogenic Pain | Not phased (device or behavioral study) | Terminated | Aug 13, 2018 | Mar 4, 2019 (actual) |
| NCT01647217 | Demodex Blepharitis Treatment Study | Phase 1 | Completed | 2014-02 | 2015-06 (actual) |
| NCT02764814 | In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye | Not phased (device or behavioral study) | Completed | 2015-07 | 2016-09 (actual) |
Open jobs 15
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Senior Technical Program Manager, Product Dev | Miami, FL, US | Oct 21, 2026 | Oct 22, 2026 | Not stated |
| Sr. Manager, Reimbursement | Not listed | Oct 21, 2026 | Oct 22, 2026 | Not stated |
| Manager, Production | Miami, FL, US | Oct 21, 2026 | Oct 22, 2026 | Not stated |
| Area Vice President, Ocular Sales | Not listed | Oct 17, 2026 | Oct 17, 2026 | Not stated |
| Representative, Sales (RI, E. Connecticut, E. Mass) | Not listed | Oct 14, 2026 | Oct 15, 2026 | Mid |
| Engineer II, Product Development | Miami, FL, US | Oct 9, 2026 | Oct 11, 2026 | Mid |
| Representative, Sales (North Alabama) | Birmingham, AL, US | Oct 9, 2026 | Oct 11, 2026 | Mid |
| Analyst, Sales Operations | Miami, FL, US | Oct 6, 2026 | Oct 11, 2026 | Mid |
| Manager, Professional Education & Content Development | Not listed | Oct 5, 2026 | Oct 11, 2026 | Senior |
| Sr. Manager, Compensation & Total Rewards | Miami, FL, US | Sep 25, 2026 | Oct 11, 2026 | Senior |
| Representative, Sales (Columbus, OH) | Columbus, OH, US | Sep 23, 2026 | Oct 11, 2026 | Mid |
| Director, Quality Operations | Miami, FL, US | Sep 14, 2026 | Oct 11, 2026 | Senior |
| Manager, Quality Control Microbiology | Miami, FL, US | Sep 14, 2026 | Oct 11, 2026 | Mid |
| Director, Corporate Partnership (Remote) | Miami, FL, US | Sep 2, 2026 | Oct 11, 2026 | Senior |
| Associate I, Manufacturing | Miami, FL, US | May 20, 2026 | Oct 11, 2026 | Entry |
Connect
See your connections at Bio-Tissue on LinkedIn (search by name, results not checked)